Skip to main content
. 2022 May 25;38(3):618–629. doi: 10.1093/ndt/gfac158

Table 3.

Overall results of last pain treatment, short-term follow-up and long-term follow-up

Overall (N = 83) Before intervention Short-term follow-up Long-term follow-up P-value before versus short P-value before versus long
Positive effect last intervention (%) 76.9 69.0
VAS score (0–100), median (IQR) 60 (50–80) 20 (0–50) 40 (10–60) <0.001 <0.001
Defined daily dose nonopioids, mean ± SD 1.2 ± 0.4 0.8 ± 0.7 0.4 ± 0.7 0.001 0.001
Defined daily dose opioids, mean ± SD 0.4 ± 0.4 0.1 ± 0.2 0.1 ± 0.2 0.01 0.01
Physical component score (0–100), mean ± SD 59 ± 22 61 ± 23 63 ± 24 0.5 0.4
Mental component score (0–100), mean ± SD 67 ± 20 64 ± 21 71 ± 17 0.3 0.03
PHQ-9 score (0–27), median (IQR) 9 (6–15) 8 (4–13) 6 (3–11) 0.5 0.001